Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2014-09-11
DOI
10.1155/2014/761608
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways
- (2014) Arshad H. Rahmani et al. Evidence-based Complementary and Alternative Medicine
- Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice
- (2014) Sahdeo Prasad et al. Cancer Research and Treatment
- Curcumin Effect on MMPs and TIMPs Genes in a Breast Cancer Cell Line
- (2013) Zeinab Korany Hassan et al. Asian Pacific Journal of Cancer Prevention
- Design andIn VitroEvaluation of a New Nano-Microparticulate System for Enhanced Aqueous-Phase Solubility of Curcumin
- (2013) Diana Guzman-Villanueva et al. Biomed Research International
- RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells
- (2012) Shadan Ali et al. CANCER LETTERS
- YAP oncogene overexpression supercharges colon cancer proliferation
- (2012) Joseph Avruch et al. CELL CYCLE
- Curcumin antifungal and antioxidant activities are increased in the presence of ascorbic acid
- (2012) Omar Arafat Kdudsi Khalil et al. FOOD CHEMISTRY
- RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER-negative breast cancer models
- (2012) BABASAHEB YADAV et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Innovative Preparation of Curcumin for Improved Oral Bioavailability
- (2011) Hiroki Sasaki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status
- (2011) Annika Gustafsson Asting et al. BMC CANCER
- Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030
- (2011) L Lin et al. BRITISH JOURNAL OF CANCER
- Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers
- (2011) Masashi Kanai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression
- (2011) B. Bao et al. CANCER RESEARCH
- Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study
- (2011) Suejung G. Kim et al. CLINICAL CANCER RESEARCH
- Design of Curcumin loaded Cellulose Nanoparticles for Prostate Cancer
- (2011) Murali Mohan Yallapu et al. CURRENT DRUG METABOLISM
- Curcumin
- (2011) Mark G. Alexandrow et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- PLGA Nanoparticles Improve the Oral Bioavailability of Curcumin in Rats: Characterizations and Mechanisms
- (2011) Xiaoxia Xie et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
- (2011) Reason Wilken et al. Molecular Cancer
- Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma
- (2011) Santosh S. Dhule et al. Nanomedicine-Nanotechnology Biology and Medicine
- Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
- (2011) Bin Bao et al. PLoS One
- PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells
- (2010) Ensaf M. Al-Hujaily et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
- (2010) Masashi Kanai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Curcumin Inhibits Constitutive STAT3 Phosphorylation in Human Pancreatic Cancer Cell lines and Downregulation of Survivin/BIRC5 Gene Expression
- (2010) W. Glienke et al. CANCER INVESTIGATION
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF
- (2010) Shadan Ali et al. CANCER RESEARCH
- Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells
- (2010) Marina Pisano et al. Molecular Cancer
- A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
- (2010) Li Lin et al. Molecular Cancer
- Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor- B Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/I B Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
- (2010) Z.-J. Sun et al. MOLECULAR PHARMACOLOGY
- Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
- (2010) Ron Epelbaum et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- RETRACTED: Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers
- (2009) Sheeja T. Tharakan et al. BIOCHEMICAL PHARMACOLOGY
- Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressorTUP1inCandida albicans
- (2009) Monika Sharma et al. BIOSCIENCE REPORTS
- New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells
- (2009) Ling Cen et al. BMC CANCER
- Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo
- (2009) Hiroyuki Shibata et al. CANCER SCIENCE
- New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells
- (2009) Li Lin et al. CANCER SCIENCE
- Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
- (2009) J. Shaikh et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A pilot cross-over study to evaluate human oral bioavailability of BCM-95®CG (BiocurcumaxTM), a novel bioenhanced preparation of curcumin
- (2009) B Antony et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model
- (2009) Ajaikumar B. Kunnumakkara et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines
- (2009) Tiffany J. Somers-Edgar et al. INVESTIGATIONAL NEW DRUGS
- Evaluation of an Oral Carrier System in Rats: Bioavailability and Antioxidant Properties of Liposome-Encapsulated Curcumin
- (2009) Makoto Takahashi et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells
- (2009) Maha H. Elamin et al. MOLECULAR CARCINOGENESIS
- Curcumin Decreases Specificity Protein Expression in Bladder Cancer Cells
- (2008) G. Chadalapaka et al. CANCER RESEARCH
- Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[ a ]pyrene-treated mice: mechanism of its anti-initiating action
- (2008) Rachana Garg et al. CARCINOGENESIS
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
- Roles of estrogen receptor and in modulating urothelial cell proliferation
- (2008) J. Teng et al. ENDOCRINE-RELATED CANCER
- Curcumin Blocks the Activation of Androgen and Interlukin-6 on Prostate-Specific Antigen Expression in Human Prostatic Carcinoma Cells
- (2008) K.-H. Tsui et al. JOURNAL OF ANDROLOGY
- Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism
- (2008) S. Yu et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of I B Kinase-Nuclear Factor- B Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
- (2008) A. L. Kasinski et al. MOLECULAR PHARMACOLOGY
- Anti cancer effects of curcumin: cycle of life and death
- (2008) Gaurisankar Sa et al. Cell Division
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now